Logo image of LMNX

Luminex Corp (LMNX) Stock Fundamental Analysis

NASDAQ:LMNX - Nasdaq -

36.99  +0.01 (+0.03%)

After market: 37 +0.01 (+0.03%)

Fundamental Rating

3

LMNX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. LMNX may be in some trouble as it scores bad on both profitability and health. LMNX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LMNX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 2.88%
ROE 4.84%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 12.4%
PM (TTM) 5.39%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for LMNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 4.59 indicates that LMNX is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.52 indicates that LMNX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 4.59
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LMNX has a Current Ratio of 8.37. This indicates that LMNX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.08 indicates that LMNX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 6.08

More info and screens

7

3. Growth

3.1 Past

LMNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 563.64%, which is quite impressive.
The earnings per share for LMNX have been decreasing by -18.61% on average. This is quite bad
The Revenue has grown by 27.73% in the past year. This is a very strong growth!
Measured over the past years, LMNX shows a quite strong growth in Revenue. The Revenue has been growing by 11.92% on average per year.
EPS 1Y (TTM)563.64%
EPS 3Y-18.22%
EPS 5Y-18.61%
EPS Q2Q%533.33%
Revenue 1Y (TTM)27.73%
Revenue growth 3Y10.83%
Revenue growth 5Y11.92%
Sales Q2Q%22.41%

3.2 Future

The Earnings Per Share is expected to grow by 50.43% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.14% on average over the next years. This is quite good.
EPS Next Y159.95%
EPS Next 2Y78.43%
EPS Next 3Y72.36%
EPS Next 5Y50.43%
Revenue Next Year16.71%
Revenue Next 2Y12.52%
Revenue Next 3Y11.99%
Revenue Next 5Y12.14%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LMNX Yearly Revenue VS EstimatesLMNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
LMNX Yearly EPS VS EstimatesLMNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 72.53, LMNX can be considered very expensive at the moment.
LMNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.45.
With a Price/Forward Earnings ratio of 33.19, LMNX can be considered very expensive at the moment.
The average S&P500 Price/Forward Earnings ratio is at 21.90. LMNX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 72.53
Fwd PE 33.19
LMNX Price Earnings VS Forward Price EarningsLMNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.82
LMNX Per share dataLMNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LMNX's earnings are expected to grow with 72.36% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y78.43%
EPS Next 3Y72.36%

More info and screens

3

5. Dividend

5.1 Amount

LMNX has a Yearly Dividend Yield of 1.08%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.08, LMNX pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.08%

5.2 History

The dividend of LMNX is nicely growing with an annual growth rate of 13.62%!
LMNX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)13.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
LMNX Yearly Dividends per shareLMNX Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 0.1 0.2 0.3

5.3 Sustainability

LMNX pays out 72.38% of its income as dividend. This is not a sustainable payout ratio.
The dividend of LMNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP72.38%
EPS Next 2Y78.43%
EPS Next 3Y72.36%
LMNX Dividend Payout.LMNX Dividend Payout, showing the Payout Ratio.LMNX Dividend Payout.PayoutRetained Earnings

More info and screens

Luminex Corp

NASDAQ:LMNX (7/13/2021, 8:00:00 PM)

After market: 37 +0.01 (+0.03%)

36.99

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners4.04%
Ins Owner Change0%
Market Cap1.75B
Analysts60
Price Target37.74 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.08%
Yearly Dividend0.4
Dividend Growth(5Y)13.62%
DP72.38%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 72.53
Fwd PE 33.19
P/S 4
P/FCF N/A
P/OCF N/A
P/B 3.59
P/tB N/A
EV/EBITDA 18.82
EPS(TTM)0.51
EY1.38%
EPS(NY)1.11
Fwd EY3.01%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.25
BVpS10.32
TBVpSN/A
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 4.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.4%
PM (TTM) 5.39%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.37
Quick Ratio 6.08
Altman-Z 4.59
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)563.64%
EPS 3Y-18.22%
EPS 5Y-18.61%
EPS Q2Q%533.33%
EPS Next Y159.95%
EPS Next 2Y78.43%
EPS Next 3Y72.36%
EPS Next 5Y50.43%
Revenue 1Y (TTM)27.73%
Revenue growth 3Y10.83%
Revenue growth 5Y11.92%
Sales Q2Q%22.41%
Revenue Next Year16.71%
Revenue Next 2Y12.52%
Revenue Next 3Y11.99%
Revenue Next 5Y12.14%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A